Cognitive · Cognitive peptide (research)
Selank
- Drug class
- Cognitive peptide (research)
- Status
- Compounded (503A)
- Reviewed
- 2026-06-01 · Dr. Ana Lisa Carr, MD
What Selank is studied for
- Calm focus (research)
- Anxiety support (research)
- Non-sedating (research)
Mechanism of action
Selank is being studied in the cognitive category. Anxiolytic nootropic for calm, focused cognition. Mechanism of action varies by study model; refer to the kindr clinical library for a deeper writeup.
Frequently asked questions
What is Selank?
Selank is a cognitive peptide. Anxiolytic nootropic for calm, focused cognition.
What is Selank studied for?
Published research has examined Selank for calm focus, anxiety support, non-sedating. Human clinical evidence varies by indication.
Is Selank FDA-approved?
No. Selank is not FDA-approved for the indications listed. It is available compounded by 503A pharmacies under clinician supervision, or for international research use only on this catalog.
How is Selank used in research?
Protocols vary by study. Selank is typically administered subcutaneously in research settings. No validated human therapeutic dose exists outside FDA-approved indications.
What are the known risks?
Long-term human safety data for Selank is limited. Theoretical risks vary by mechanism. Any human use should be supervised by a licensed clinician.
